Development of a phenotypic screening assay to measure activation of cancer-associated fibroblasts
BackgroundIn cancer metastasis, tumor cells condition distant tissues to create a supportive environment, or metastatic niche, by driving the activation of cancer-associated fibroblasts (CAFs). These CAFs remodel the extracellular matrix, creating a microenvironment that supports tumor growth and co...
Saved in:
| Main Authors: | Marcus M. Ilg, Alice R. Lapthorn, Sophie L. Harding, Tariq Minhas, Gouri Koduri, Stephen A. Bustin, Selim Cellek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1526495/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay
by: Elisabeth Bäck, et al.
Published: (2025-04-01) -
SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis
by: Carina Magdaleno, et al.
Published: (2024-12-01) -
Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis
by: Haohui Lin, et al.
Published: (2025-02-01) -
TRPC3 inhibition induces myofibroblast differentiation in diabetic dermal fibroblasts
by: Gemma Toogood, et al.
Published: (2025-04-01) -
A secretome screen in primary human lung fibroblasts identifies FGF9 as a novel regulator of cellular senescence
by: Jenna Bradley, et al.
Published: (2025-04-01)